Outset Medical, Inc. (OM)

NMS – Real vaqt narxi. Valyuta: USD

3.84

+0.19 (5.21%)

Yopilishda: May 12, 2026, 4:00 PM EDT

3.87

+0.03 (0.78%)

Bozordan keyin: May 12, 2026, 7:01 PM EDT

09.05.2026

Outset Medical, Inc. (OM) Q1 2026 Earnings Call Transcript

08.05.2026

Outset Medical Q1 Earnings Call Highlights

Outset Medical NASDAQ: OM reported first-quarter 2026 revenue of $27.9 million, as management pointed to “consistent execution” in console utilization, new customer additions, gross margin expansion, and cash discipline, while acknowledging that capital order timing weighed on results.

07.05.2026

Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates

Outset Medical, Inc. (OM) came out with a quarterly loss of $0.83 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares to a loss of $3.24 per share a year ago.

07.05.2026

Outset Medical Reports First-Quarter Results

SAN JOSE, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today reported financial results for the first quarter ended March 31, 2026.

27.04.2026

Outset Medical to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026

SAN JOSE, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced that it will release financial results for the first quarter 2026 after the close of trading on Thursday, May 7, 2026.

13.04.2026

Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are urged to contact the firm immediately at no cost or obligation, as there may be limited time to enforce your rights. We would handle the matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

08.04.2026

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN JOSE, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity (the “Company”), today announced that the Compensation Committee of its Board of Directors approved equity awards under the Company's Inducement Plan, as a material inducement to employment to Derick Elliott, the Company's newly appointed Executive Vice President of Commercial, as well as one newly appointed non-executive employee, in each case, who were not previous employees or directors of the Company.

Videolar

No Data

There is no data to display

Press-relizlar

07.05.2026

Outset Medical Reports First-Quarter Results

13.04.2026

Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

08.04.2026

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

06.04.2026

Outset Medical Names Derick Elliott as Executive Vice President of Commercial

SAN JOSE, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced the appointment of Derick Elliott as Executive Vice President of Commercial, effective immediately.

Outset Medical, Inc. (OM)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Outset Medical, Inc. (OM)

Outset Medical, Inc. (OM) Q1 2026 Earnings Call Transcript

Outset Medical Q1 Earnings Call Highlights

Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates

Outset Medical Reports First-Quarter Results

Outset Medical to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026

Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Videolar

No Data

Press-relizlar

Outset Medical Reports First-Quarter Results

Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Outset Medical Names Derick Elliott as Executive Vice President of Commercial

Outset Medical, Inc. (OM) Q1 2026 Earnings Call Transcript

Outset Medical Q1 Earnings Call Highlights

Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates

Outset Medical Reports First-Quarter Results

Outset Medical to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026

Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Videolar

No Data

Press-relizlar

Outset Medical Reports First-Quarter Results

Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Outset Medical Names Derick Elliott as Executive Vice President of Commercial

Search stocks

Outset Medical, Inc. (OM)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Outset Medical, Inc. (OM)

Outset Medical, Inc. (OM) Q1 2026 Earnings Call Transcript

Outset Medical Q1 Earnings Call Highlights

Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates

Outset Medical Reports First-Quarter Results

Outset Medical to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026

Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Videolar

No Data

Press-relizlar

Outset Medical Reports First-Quarter Results

Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Outset Medical Names Derick Elliott as Executive Vice President of Commercial

Outset Medical, Inc. (OM) Q1 2026 Earnings Call Transcript

Outset Medical Q1 Earnings Call Highlights

Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates

Outset Medical Reports First-Quarter Results

Outset Medical to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026

Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Videolar

No Data

Press-relizlar

Outset Medical Reports First-Quarter Results

Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Outset Medical Names Derick Elliott as Executive Vice President of Commercial